Skip to main content
Tatiana Prowell, MD, Oncology, Baltimore, MD, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

TatianaMichelleProwellMD

Oncology • Baltimore, MD

Breast Cancer

Associate Professor of Oncology Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

Join to view full profile

Dr. Prowell is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Prowell's full profile

Already have an account?

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2002 - 2006
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 1999 - 2002
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1999
  • Bard College
    Bard CollegeBA, English, 1990 - 1994

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2002 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • FDA Group Recognition Award 2011-2012
  • Award for Excellence in Communication Food & Drug Administration, 2010
  • Young Investigator Award American Society of Clinical Oncology, 2004
  • Join now to see all

Publications & Presentations

PubMed

Books/Book Chapters

  • Breast Cancer Management and Molecular Medicine: Towards Tailored Approaches 
    Chapter: Metastatic breast cancer: Tailored endocrine therapy for premenopausal women. 
    Page 445 - 458Prowell T, Davidson NEditors: Piccart M, Wood W, Hung M-C, Solin L, Cardoso F..Springer-Verlag2006
  • The Osler Medical Handbook 
    Chapter: Neutropenic Fever. 
    Page 537 - 544Prowell T, Smith BEditors: Cheng A, Zaas A..Mosby, Philadelphia, PAEdition Firs,2003
  • The Osler Medical Handbook 
    Chapter: Asthma. 
    Page 867 - 880Prowell T, Liu MEditors: Cheng A, Zaas A..Mosby, Philadelphia, PAEdition Firs,2003

Abstracts/Posters

  • A Definition of a High-Risk Early-Breast Cancer Population Based on Data from the Collaborative Trials in Neoadjuvant Breast Cancer (CTNeoBC) meta-analysis.
    Cortazar P, Zhang L, Untch M, Mehta K, Costantino J, Wolmark N, Bonnefoi H, Cameron D, Gianni L, Valagussa P, Zujewski J, Justice R, Loibl S, Wickerham L, Bogaerts J, ..., Cancer Res, 1/1/2013
  • Meta-analysis Results from the Collaborative Trials in Neoadjuvant Breast Cancer (CTneoBC).
    Cortazar P, Zhang L, Untch M, Mehta K, Costantino J, Wolmark N, Bonnefoi H, Cameron D, Gianni L, Valagussa P, Zujewski J, Justice R, Loibl S, Wickerham L, Bogaerts J, ..., Cancer Res

Lectures

  • Seeking New Opportunities: What to Look for and How to Prepare for Them 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
  • "Pathological Complete Response: Is It the Holy Grail?" 
    Baltimore, MD - 3/7/2014
  • Grand Rounds: "Preoperative Systemic Therapy for Breast Cancer: Considerations for Investigators, Clinicians, and Patients." 
    Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Hanover, NH - 2/18/2014
  • Join now to see all

Other

  • Guidance for Industry: Pathologic Complete Response in Neoadjuvant Treatment of High-Risk Early-Stage Breast Cancer: Use as an Endpoint to Support Accelerated Approval 
    Prowell T
    http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM305501.pdf
  • "Accelerating the Search for Breast Cancer Therapies for Triple Negative Breast Cancer." 
    Tatiana Michelle Prowell, MD, CBS Biocentury TV
    Washington, DC - 7/29/2012
  • Webinar: "Draft Guidance on Using Pathologic Complete Response as an Endpoint to Support Accelerated Approval of Drugs to Treat Early-Stage Breast Cancer." 
    Tatiana Michelle Prowell, MD
    Office of Medical Policy, Center for Drug Evaluation and Research, Food & Drug Administration, Silve - 6/28/2012
  • Join now to see all

Press Mentions

  • CMOs: 11 Things Your Employees, Colleagues Want to Tell You
    CMOs: 11 Things Your Employees, Colleagues Want to Tell YouFebruary 6th, 2023
  • The Irony and Ignominy of Medical Conferences as Superspreader Events
    The Irony and Ignominy of Medical Conferences as Superspreader EventsJune 14th, 2022
  • As Reports of ‘Paxlovid Rebound’ Increase, Covid Researchers Scramble for Answers
    As Reports of ‘Paxlovid Rebound’ Increase, Covid Researchers Scramble for AnswersMay 24th, 2022
  • Join now to see all

Professional Memberships

Hospital Affiliations

Dr. Tatiana Prowell, Dr. Tatiana Prowell, MD, Dr. T Prowell, Dr. Tatiana Michelle Prowell